Sutimlimab ( designated) a novel therapeutic is a highly selective biologic with a chemical designation of 2049079641 . The drug works by specifically blocking C5 , a constituent within the https://bookmark-dofollow.com/story28405919/sutimlimab-the-deep-investigation-into-2049079-64-1-antibody